Endothelin-3 decreases Ca2+ uptake in platelet membrane vesicles

J Cardiovasc Pharmacol. 1995:26 Suppl 3:S145-7.

Abstract

To analyze the mechanisms by which endothelin-3 (ET-3) attenuates agonist-mediated Ca2+ mobilization from an internal pool, we investigated ET-3 effects on 45Ca2+ uptake in platelet membrane vesicles. They were compared to those of thapsigargin (Tg), a specific inhibitor of the dense tubule Ca2+ pumps. In the absence of ATP, ET-3 up to 1 microM did not affect the amount of Ca2+ bound to membrane sites. In the presence of ATP, ET-3 dose-dependently reduced the initial rate and the extent of Ca2+ uptake (p < 0.001). In comparison, Tg dose-dependently inhibited both the ATP-independent Ca2+ binding (p < 0.001) and the ATP-dependent Ca2+ accumulation (p < 0.001), with half-maximal effects at 7 nM. Pretreatment with 1 microM ET-3 decreased the inhibitory effect of 10 nM Tg, but only on the initial rate of ATP-dependent Ca2+ uptake (p = 0.04; n = 6). These results indicate that ET-3 is functionally coupled to Ca(2+)-ATPases of the dense tubules. Its inhibitory effects are probably due to inhibition of the catalytic cycle of the Ca2+ pumps. Such inhibition could lead to a depletion of Ca2+ stores and therefore to reduced Ca2+ release in response to agonists.

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism
  • Calcium / metabolism*
  • Endothelins / pharmacology*
  • Humans
  • Ion Transport / drug effects
  • Terpenes / pharmacology
  • Thapsigargin

Substances

  • Endothelins
  • Terpenes
  • Thapsigargin
  • Adenosine Triphosphate
  • Calcium